Wound Treatments - Sweden
Current value sales of wound treatments increased by more than 3% in current value terms in 2009, to reach SEK111 million. Sales growth was driven by the increasing share of designed or decorated plasters. These drove value growth, as they are more expensive than standard plasters. In addition, a number of situation-specific wound treatments were launched towards the end of the review period, and these also drove growth. Examples of such products include water-resistant plasters, quick healing...
Euromonitor International's Wound Treatments Products in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Other Wound Treatments, Sticking Plasters.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Wound Treatments Products in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Other Wound Treatments, Sticking Plasters.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Switches Continue To Boost Value Sales in 2009
New Pharmacy Legislation
Multinationals Dominate
Distribution Patterns Will Change
Wider Distribution Results in Stronger Competition
Key Trends and Developments
Deregulated OTC Market
H1n1
Trends Come and Go in Vitamins and Dietary Supplements
Older Population
Multinationals Dominate
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Advertising
Standardised Packaging Requirements
End of Pharmacy Monopoly in 2009
Vitamins and Dietary Supplements Registration and Classification
Advertising
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Analgesics
Cough, Cold and Allergy (hay Fever) Remedies
Digestive Remedies
Medicated Skin Care
Nrt Smoking Cessation Aids
Eye Care
Ear Care
Adult Mouth Care
Calming and Sleeping Products
Wound Treatments
OTC Obesity
Emergency Contraception
OTC Statins
OTC Triptans
Vitamins and Dietary Supplements
Slimming Products
Sports Nutrition Products
Herbal/traditional Products
Summary 2 Research Sources
Abigo Medical Ab
Strategic Direction
Key Facts
Summary 3 Abigo Medical AB: Key Facts
Summary 4 Abigo Medical AB: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Abigo Medical AB: Competitive Position 2009, GBO level
Antula Healthcare Ab
Strategic Direction
Key Facts
Summary 6 Antula Healthcare AB: Key Facts
Summary 7 Antula Healthcare AB: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Antula Healthcare AB: Competitive Position 2009
Biophausia Ab
Strategic Direction
Key Facts
Summary 9 Biophausia AB: Key Facts
Summary 10 Biophausia AB: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Biophausia AB: Competitive Position 2009
Midelfart Sonesson Ab
Strategic Direction
Key Facts
Summary 12 Midelfart Sonesson AB: Key Facts
Summary 13 Midelfart Sonesson AB: Operational Indicators
Company Background
Production
Summary 14 Midelfart Sonesson AB: Production Statistics 2009
Competitive Positioning
Summary 15 Midelfart Sonesson AB: Competitive Position 2009, GBO level
Svenska Örtmedicinska Institutet
Strategic Direction
Key Facts
Summary 16 Svenska Örtmedicinska Institutet: Key Facts
Summary 17 Svenska Örtmedicinska Institutet: Operational Indicators
Production
Summary 18 Svenska Örtmedicinska Institutet AB: Production Statistics 2009
Competitive Positioning
Summary 19 Svenska Örtmedicinska Institutet: Competitive Position 2009, GBO level
Trends
Category Data
Table 12 Sales of Wound Treatments by Subsector: Value 2004-2009
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Table 14 Wound Treatments Company Shares by Value 2005-2009
Table 15 Wound Treatments Brand Shares by Value 2006-2009
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
Switches Continue To Boost Value Sales in 2009
New Pharmacy Legislation
Multinationals Dominate
Distribution Patterns Will Change
Wider Distribution Results in Stronger Competition
Key Trends and Developments
Deregulated OTC Market
H1n1
Trends Come and Go in Vitamins and Dietary Supplements
Older Population
Multinationals Dominate
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Advertising
Standardised Packaging Requirements
End of Pharmacy Monopoly in 2009
Vitamins and Dietary Supplements Registration and Classification
Advertising
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Analgesics
Cough, Cold and Allergy (hay Fever) Remedies
Digestive Remedies
Medicated Skin Care
Nrt Smoking Cessation Aids
Eye Care
Ear Care
Adult Mouth Care
Calming and Sleeping Products
Wound Treatments
OTC Obesity
Emergency Contraception
OTC Statins
OTC Triptans
Vitamins and Dietary Supplements
Slimming Products
Sports Nutrition Products
Herbal/traditional Products
Summary 2 Research Sources
Abigo Medical Ab
Strategic Direction
Key Facts
Summary 3 Abigo Medical AB: Key Facts
Summary 4 Abigo Medical AB: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Abigo Medical AB: Competitive Position 2009, GBO level
Antula Healthcare Ab
Strategic Direction
Key Facts
Summary 6 Antula Healthcare AB: Key Facts
Summary 7 Antula Healthcare AB: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Antula Healthcare AB: Competitive Position 2009
Biophausia Ab
Strategic Direction
Key Facts
Summary 9 Biophausia AB: Key Facts
Summary 10 Biophausia AB: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Biophausia AB: Competitive Position 2009
Midelfart Sonesson Ab
Strategic Direction
Key Facts
Summary 12 Midelfart Sonesson AB: Key Facts
Summary 13 Midelfart Sonesson AB: Operational Indicators
Company Background
Production
Summary 14 Midelfart Sonesson AB: Production Statistics 2009
Competitive Positioning
Summary 15 Midelfart Sonesson AB: Competitive Position 2009, GBO level
Svenska Örtmedicinska Institutet
Strategic Direction
Key Facts
Summary 16 Svenska Örtmedicinska Institutet: Key Facts
Summary 17 Svenska Örtmedicinska Institutet: Operational Indicators
Production
Summary 18 Svenska Örtmedicinska Institutet AB: Production Statistics 2009
Competitive Positioning
Summary 19 Svenska Örtmedicinska Institutet: Competitive Position 2009, GBO level
Trends
Category Data
Table 12 Sales of Wound Treatments by Subsector: Value 2004-2009
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Table 14 Wound Treatments Company Shares by Value 2005-2009
Table 15 Wound Treatments Brand Shares by Value 2006-2009
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
